Cart
sales@molnova.com
Gnetifolin K
CAS No. 193806-40-5
Gnetifolin K( —— )
Catalog No. M33077 CAS No. 193806-40-5
Gnetifolin K (GnetifolinK) is a novel stilbene diglucoside from Gnetum parvifolium with potential neuroprotective activity for the study of DNA damage.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 567 | In Stock |
|
| 5MG | 459 | In Stock |
|
| 10MG | 657 | In Stock |
|
| 25MG | 1026 | In Stock |
|
| 50MG | 1386 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGnetifolin K
-
NoteResearch use only, not for human use.
-
Brief DescriptionGnetifolin K (GnetifolinK) is a novel stilbene diglucoside from Gnetum parvifolium with potential neuroprotective activity for the study of DNA damage.
-
DescriptionGnetifolin K (GnetifolinK) is a novel stilbene diglucoside from Gnetum parvifolium with potential neuroprotective activity for the study of DNA damage.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number193806-40-5
-
Formula Weight582.55
-
Molecular FormulaC27H34O14
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(C1=C(OC)C=C(/C=C/C2=CC(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)=CC(O)=C2)C=C1)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
[Val4]-Angiotensin I...
[Val4] Angiotensin III is an angiotension III peptide. [Val4] Angiotensin III is a potent full agonist of Gαq and βarr2 response, with pEC50 values of 8.31 and 8.44, respectively.
-
Murrayanine
Murrayanine is a natural product isolated from leaves and stems of Murraya kwangsiensis (C.C. Huang) C.C. Huang (Rutaceae).
-
Brentuximab vedotin
Brentuximab vedotin (SGN-35) is a CD30-targeting antibody-active molecule conjugate (ADC) that combines a CD30 monoclonal antibody with the microtubule disrupting agent monomethylauristatin E for the study of lymphoma.
